找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Cardiorenal Syndrome in Heart Failure; W. H. Wilson Tang,Frederik H. Verbrugge,Wilfried M Book 2020 Springer Nature Switzerland AG 2020 Ca

[复制链接]
查看: 6658|回复: 57
发表于 2025-3-21 19:08:56 | 显示全部楼层 |阅读模式
书目名称Cardiorenal Syndrome in Heart Failure
编辑W. H. Wilson Tang,Frederik H. Verbrugge,Wilfried M
视频video
概述Features a multidisciplinary approach with contributions from both cardiologists and nephrologists.Contains a practically applicable case-based approach to managing patients with refractory congestion
图书封面Titlebook: Cardiorenal Syndrome in Heart Failure;  W. H. Wilson Tang,Frederik H. Verbrugge,Wilfried M Book 2020 Springer Nature Switzerland AG 2020 Ca
描述.This comprehensive manual reviews the management of cardiorenal syndrome in heart failure. Chapters are structured in a practically applicable and easy-to-follow format with realistic case vignettes and key clinical management questions and answers, followed by a brief discussion of underlying pathophysiological mechanisms of a patient with cardiorenal syndrome. Building from this case, key questions are posed that are relevant to the clinical management and then potential evidence-based treatment strategies are proposed. Topics covered include loop diuretic resistance in acute and chronic heart failure, abdominal congestion, low output failure and potential diuretic complications due to hyponatremia. ..Cardiorenal Syndrome in Heart Failure. thoroughly reviews cardiorenal syndrome from the perspective of both the cardiologist and nephrologist. Its case-based approach makes it an ideal resource for both practising and trainee cardiology and nephrology practitioners. .
出版日期Book 2020
关键词Cardio-Renal Syndrome; Loop diuretic resistance; Heart Failure; Diuretics; Ultrafiltration; chronic kidne
版次1
doihttps://doi.org/10.1007/978-3-030-21033-5
isbn_softcover978-3-030-21035-9
isbn_ebook978-3-030-21033-5
copyrightSpringer Nature Switzerland AG 2020
The information of publication is updating

书目名称Cardiorenal Syndrome in Heart Failure影响因子(影响力)




书目名称Cardiorenal Syndrome in Heart Failure影响因子(影响力)学科排名




书目名称Cardiorenal Syndrome in Heart Failure网络公开度




书目名称Cardiorenal Syndrome in Heart Failure网络公开度学科排名




书目名称Cardiorenal Syndrome in Heart Failure被引频次




书目名称Cardiorenal Syndrome in Heart Failure被引频次学科排名




书目名称Cardiorenal Syndrome in Heart Failure年度引用




书目名称Cardiorenal Syndrome in Heart Failure年度引用学科排名




书目名称Cardiorenal Syndrome in Heart Failure读者反馈




书目名称Cardiorenal Syndrome in Heart Failure读者反馈学科排名




单选投票, 共有 1 人参与投票
 

0票 0.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

1票 100.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 23:48:50 | 显示全部楼层
发表于 2025-3-22 02:25:39 | 显示全部楼层
发表于 2025-3-22 06:23:29 | 显示全部楼层
P. Bach,S. Cluzeau,C. Lambermontuts into central autonomic nuclei responsible for cardiovascular control and sympathetic outflow. In disease states such as heart failure and renal failure, increased renal sympathetic nerve activity can further worsen renal function, with a shift from inhibitory to “less inhibitory” (or potentially
发表于 2025-3-22 09:04:31 | 显示全部楼层
https://doi.org/10.1007/978-1-349-26729-3ir effectiveness or induce worrisome worsening of renal function. It is important to understand and leverage the pharmacokinetic and pharmacodynamic properties of diuretic drugs, if therapeutic success is to be achieved. At its simplest, a diuretic must be administered or ingested and absorbed, must
发表于 2025-3-22 13:27:09 | 显示全部楼层
发表于 2025-3-22 17:49:50 | 显示全部楼层
发表于 2025-3-22 23:11:52 | 显示全部楼层
https://doi.org/10.1007/978-1-349-26729-3ent hemodialysis itself causes significant hemodynamic stress and vascular changes as well as a potential high-output state from arteriovenous fistula that can be linked to left ventricular hypertrophy and myocardial ischemia and stunning. Cardiovascular and metabolic changes such as fluid overload,
发表于 2025-3-23 01:48:34 | 显示全部楼层
发表于 2025-3-23 07:43:03 | 显示全部楼层
https://doi.org/10.1007/978-1-349-26729-3chieve symptomatic relief. The management of heart failure through the use of intravenous diuretics is at times limited due to renal function. An elevated Cr level, which has previously been associated with poor outcomes, is a common end-point in most AHF trials. However, recent data has called into
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-29 21:37
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表